Buy back

Natco Pharma Limited has informed the Exchange that the board of directors of the Company, at its meeting held November 5, 2018, have approved the buyback of fully paid-up equity shares of face value of Rs. 2/- (Rupees Two only) each of the Company (“Equity Shares”) at a price not exceeding Rs. 1,000/- (Rupees One Thousand only) per Equity Share (“Maximum Buyback Price”) excluding any other expenses incurred or to be incurred for the Buyback like filing fees payable to SEBI, Stock Exchanges fees, advisors fees, public announcement, publication expenses, transaction cost viz., brokerage, applicable taxes such as securities transaction tax, stamp duty, etc., and any other incidental and related expenses (“Transaction Cost”) for an aggregate amount of Rs.2,500 Millions (Rupees Two thousand five hundred Millions only) (“Maximum Buyback Size”) from the open market through stock exchange mechanism in such manner as may be prescribed in the Companies Act, 2013 (as amended) and rules made thereunder and the Securities and Exchange Board of India (Buy Back of Securities) Regulations, 2018 (“Buyback Regulations”) (“Buyback”).

Public Announcement 2018

Daily Buyback Reports 19/11/2018

Daily Buyback Reports 20/11/2018

Daily Buyback Reports 21/11/2018

Daily Buyback Reports 22/11/2018

Daily Buyback Reports 26/11/2018

Daily Buyback Reports 27/11/2018

Daily Buyback Reports 28/11/2018

Daily Buyback Reports 29/11/2018

Daily Buyback Reports 30/11/2018

Daily Buyback Reports 3/12/2018

Daily Buyback Reports 4/12/2018

Daily Buyback Reports 5/12/2018

Daily Buyback Reports 6/12/2018

Daily Buyback Reports 7/12/2018

Daily Buyback Reports 10/12/2018

Daily Buyback Reports 11/12/2018

Daily Buyback Reports 12/12/2018

Daily Buyback Reports 13/12/2018

Daily Buyback Reports 14/12/2018